The global quality of medicines for preventing and managing hypertensive disorders of pregnancy is concerning. A systematic review of 33 studies from 27 countries found substandard medications across all recommended drugs. Issues included API specification failures, contaminants, pH criteria, degradation, and heavy metal contamination. Urgent action is needed to address safety and efficacy concerns. #MaternalHealth ...







